Tang Capital Management Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.97B
Q ending 2026-03-31
Prior quarter
$2.02B
Q ending 2025-12-31
Change
-2.7% QoQ · +8.9% YoY
Positions
51
reported holdings
Largest positions
All 51 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | AUPH | Shares | $181.2M | 12.2M |
| Celcuity Inc | CELC | Shares | $119.8M | 1.1M |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $114.2M | 1.2M |
| Galapagos Nv | LKFT | Shares | $113.6M | 3.8M |
| State Str Spdr S&P 500 Etf T | SPY | Shares | $109.3M | 168K |
| Kiniksa Pharmaceuticals Intl | Shares | $108.8M | 2.3M | |
| Capricor Therapeutics Inc | CAPR | Shares | $103.4M | 3.4M |
| Ptc Therapeutics Inc | PTCT | Shares | $102.2M | 1.5M |
| Spyre Therapeutics Inc | SYRE | Shares | $95.4M | 1.9M |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $92.1M | 4.6M |
| Compass Therapeutics Inc | CMPX | Shares | $88.8M | 16.8M |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $83.4M | 1.2M |
| Immunocore Hldgs Plc | IMCR | Shares | $79.9M | 2.6M |
| Anaptysbio Inc | ANAB | Shares | $73.8M | 1.3M |
| Corcept Therapeutics Inc | CORT | Shares | $60.5M | 1.5M |
| Ani Pharmaceuticals Inc | ANIP | Shares | $54.4M | 708K |
| Insmed Inc | INSM | Shares | $42.5M | 260K |
| Biontech Se | BNTX | Shares | $41.8M | 470K |
| Viridian Therapeutics Inc | VRDN | Shares | $35.1M | 1.8M |
| Atea Pharmaceuticals Inc | AVIR | Shares | $25.9M | 4.8M |
| Precigen Inc | PGEN | Shares | $24.8M | 6.4M |
| Dianthus Therapeutics Inc | DNTH | Shares | $22.2M | 265K |
| Compass Pathways Plc | CMPS | Shares | $22.1M | 4.0M |
| Crescent Biopharma Inc. | Shares | $21.3M | 1.2M | |
| Stoke Therapeutics Inc | STOK | Shares | $16.3M | 500K |
| Viking Therapeutics Inc | VKTX | Shares | $16.3M | 500K |
| Ideaya Biosciences Inc | IDYA | Shares | $15.0M | 450K |
| Nuvation Bio Inc | NUVB | Shares | $13.5M | 3.1M |
| Pliant Therapeutics Inc | PLRX | Shares | $7.7M | 6.1M |
| Journey Med Corp | DERM | Shares | $7.6M | 1.6M |
| Janux Therapeutics Inc | JANX | Shares | $7.0M | 500K |
| Biogen Inc | BIIB | Shares | $6.4M | 35K |
| Urogen Pharma Ltd | Shares | $6.3M | 350K | |
| Arvinas Inc | ARVN | Shares | $5.7M | 539K |
| Pmv Pharmaceuticals Inc | PMVP | Shares | $5.3M | 4.2M |
| Moderna Inc | MRNA | Shares | $5.1M | 100K |
| Heron Therapeutics Inc | HRTX | Shares | $5.0M | 6.3M |
| Kezar Life Sciences Inc | 2KZ0 | Shares | $4.9M | 664K |
| Wave Life Sciences Ltd | Shares | $4.3M | 600K | |
| Lenz Therapeutics Inc | LENZ | Shares | $4.1M | 451K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $3.4M | 100K |
| Erasca Inc | ERAS | Shares | $3.2M | 200K |
| Coherus Oncology Inc | CHRS | Shares | $3.2M | 1.9M |
| Nkarta Inc | NKTX | Shares | $3.1M | 1.5M |
| Altimmune Inc | ALT | Shares | $2.1M | 666K |
| Evolus Inc | EOLS | Shares | $2.0M | 483K |
| Abeona Therapeutics Inc | ABEO | Shares | $1.8M | 400K |
| Fate Therapeutics Inc | FATE | Shares | $1.4M | 1.2M |
| Neumora Therapeutics Inc. | NMRA | Shares | $858K | 440K |
| Lexicon Pharmaceuticals Inc | LXRX | Shares | $624K | 400K |
| Rocket Pharmaceuticals Inc | RCKT | Shares | $358K | 100K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.